| Oslo | |
| 0 | |
| A novel implantable osmotic sensor for long-term continuous glucose measurement for communication to outside reader. | |
| The purpose of the SENCELL device is to provide a painless, accurate and convenient glucose measurement solution with long usage time for daily use in patients with diabetes mellitus. The miniaturized 2*6 mm Lifecare SENCELL device is designed to continuously measure glucose in the interstitial fluid for a long term duration that is comparable or longer than existing product alternatives. | |
| FRISVOLD Rune | |
| www.lifecare.no | |
| Private Equity |
Fiche créée le 10/04/2016 par 
Guillaume vue 21 fois.